A list of authors and their affiliations appears at the end of the paper The genetic architecture of autism spectrum disorder involves the interplay of common and rare variants and their impact on hundreds of genes. Using exome sequencing, here we show that analysis of rare coding variation in 3,871 autism cases and 9,937 ancestry-matched or parental controls implicates 22 autosomal genes at a false discovery rate (FDR) , 0.05, plus a set of 107 autosomal genes strongly enriched for those likely to affect risk (FDR , 0.30). These 107 genes, which show unusual evolutionary constraint against mutations, incur de novo loss-of-function mutations in over 5% of autistic subjects. Many of the genes implicated encode proteins for synaptic formation, transcriptional regulation and chromatin-remodelling pathways. These include voltage-gated ion channels regulating the propagation of action potentials, pacemaking and excitability-transcription coupling, as well as histone-modifying enzymes and chromatin remodellers-most prominently those that mediate post-translational lysine methylation/demethylation modifications of histones.
would expect to observe this in approximately two such genes by chance. While we expect only two de novo Mis3 events in these 18 genes, we observe 16 (P 5 9.2 3 10 211 , Poisson test). Because most of our data exist in cases and controls and because we observed an additional excess of transmitted LoF events in the 18 genes, it is evident that the optimal analytical framework must involve an integration of de novo mutation with variants observed in cases and controls and transmitted or untransmitted from carrier parents. Investigating beyond de novo LoFs is also critical given that many ASD risk genes and loci have mutations that are not completely penetrant.
Transmission and de novo association
We adopted TADA (transmission and de novo association), a weighted, statistical model integrating de novo, transmitted and case-control variation 20 . TADA uses a Bayesian gene-based likelihood model including per-gene mutation rates, allele frequencies, and relative risks of particular classes of sequence changes. We modelled both LoF and Mis3 sequence variants. Because no aggregate association signal was detected for inherited Mis3 variants, they were not included in the analysis. For each gene, variants of each class were assigned the same effect on relative risk. Using a prior probability distribution of relative risk across genes for each class of variants, the model effectively weighted different classes of variants in this order: de novo LoF . de novo Mis3 . transmitted LoF, and allowed for a distribution of relative risks across genes for each class. The strength of association was assimilated across classes to produce a gene-level Bayes factor with a corresponding FDR q value. This framework increases the power compared to the use of de novo LoF variants alone (Extended Data Fig. 2 ).
TADA identified 33 autosomal genes with an FDR , 0.1 (Table 1 ) and 107 with an FDR , 0.3 ( Supplementary Tables 2 and 3 and Extended Data Fig. 3) . Of the 33 genes, 15 (45.5%) are known ASD risk genes 9 ; 11 have been reported previously with mutations in ASD patients but were not classed as true risk genes owing to insufficient evidence (SUV420H1 (refs 11, 15) , ADNP 12 , BCL11A 15 , CACNA2D3 (refs 15, 21) , CTTNBP2 (ref. 15 ), GABRB3 (ref. 21) , CDC42BPB 13 , APH1A 14 , NR3C2 (ref. 15) , SETD5 (refs 14, 22) and TRIO 11 ) and 7 are completely novel (ASH1L, MLL3 (also known as KMT2C), ETFB, NAA15, MYO9B, MIB1 and VIL1). ADNP mutations have recently been identified in 10 patients with ASD and other shared clinical features 23 . Two of the newly discovered genes, ASH1L and MLL3, converge on chromatin remodelling. MYO9B plays a key role in dendritic arborization 24 . MIB1 encodes an E3 ubiquitin ligase critical for neurogenesis 25 and is regulated by miR-137 (ref. 26 ), a microRNA that regulates neuronal maturation and is implicated in schizophrenia risk 27 .
When the WES data from genes with an FDR , 0.3 were evaluated for the presence of deletion copy number variants (CNVs) (such CNVs are functionally equivalent to LoF mutations), 34 CNVs meeting quality and frequency constraints (Supplementary Information) were detected in 5,781 samples (Extended Data Fig. 1 ). Of the 33 genes with an FDR , 0.1, 3 contained deletion CNVs mapping to 3 ASD subjects and one parent. Of the 74 genes meeting the criterion 0.1 # FDR , 0.3, about one-third could be false positives. Deletion CNVs were found in 14 of these genes and the data supported risk status for 10 of them (Extended Data Table 1 and Extended Data Fig. 4 ). Two of these ten, NRXN1 and SHANK3, were previously implicated in ASD 2,3,10 . The risk from deletion CNVs, as measured by the odds ratio, is comparable to that from LoF SNVs in cases versus controls or transmission of LoF variants from parents to offspring.
Estimated odds ratios of top genes
Inherent in our conception of the biology of ASD is the notion that there is variation between genes in their impact on risk; for a given class of variants (for example, LoF) some genes have a large impact, others smaller, and still others have no effect at all. In addition, misannotation of variants, among other confounds, can yield false variant calls in subjects (Supplementary Information). These confounds can often be overcome by examining the data in a manner orthogonal to gene discovery. For example, females have greatly reduced rates of ASD relative to males (a 'female protective effect'). Consequently, and regardless of whether this is diagnostic bias or biological protection, females have a higher liability threshold, requiring a larger genetic burden before being diagnosed 22, 28, 29 . A corollary is that if a variant has the same effect on autism liability in males as it does in females, that variant will be present at a higher frequency in female ASD cases compared to males. Importantly, the magnitude of the difference is proportional to risk as measured by the odds ratio; hence, the effect on risk for a class of variants can be estimated from the difference in frequency between males and females.
Genes with an FDR , 0.1 show profound female enrichment for de novo events (P 5 0.005 for LoF, P 5 0.004 for Mis3), consistent with de novo events having large impacts on liability (odds ratio $ 20; Extended Data Fig. 5 ). However, genes with an FDR between 0.1 and 0.3 show substantially less enrichment for female events, consistent with a modest impact for LoF variants (odds ratio range 2-4, whether transmitted or de novo) and little to no effect from Mis3 variants. The TADA analysis of LoF and damaging missense variants found to be de novo in ASD subjects, inherited by ASD subjects, or present in ASD subjects (versus control subjects). dnLoF, de novo LoF events. a, Enrichment of 107 TADA genes in: FMRP targets from two independent data sets 31, 32 and their overlap; RBFOX targets; RBFOX targets with predicted alterations in splicing; RBFOX1 and H3K4me3 overlapping targets; genes with de novo mutations in schizophrenia (SCZ); human orthologues of Genes2Cognition (G2C) mouse synaptosome (SYN) or PSD genes; constrained genes; and genes encoding mitochondrial proteins (as a control). Red bars indicate empirical P values (Supplementary Information). b, Synaptic proteins encoded by TADA genes. c, De novo Mis3 variants in Na v 1.2 (SCN2A). The four repeats (I-IV) with P-loops, the EF-hand, and the IQ domain are shown, as are the four amino acids (DEKA) forming the inner ring of the ionselectivity filter. d, Variants in Ca v 1.3 (CACNA1D). Part of the channel is shown, including helices one and six (S1 and S6) for domains I-IV, the NSCaTE motif, the EF-hand domain, the pre-IQ, IQ, proximal (PCRD) and distal (DCRD) C-terminal regulatory domains, the proline-rich region, and the PDZ domain-binding motif.
results are consistent with inheritance patterns: LoF mutations in FDR , 0.1 genes are rarely inherited from unaffected parents whereas those in the 0.1 # FDR , 0.3 group are far more often inherited than they are de novo mutations. By analysing the distribution of relative risk over inferred ASD genes 20 , the number of ASD risk genes can be estimated. The estimate relies on the balance of genes with multiple de novo LoF mutations versus those with only one: the larger the number of ASD genes, the greater proportion that will show only one de novo LoF. This approach yields an estimate of 1,150 ASD genes (Supplementary Information). While there are many more genes to be discovered, many will have a modest impact on risk compared to the genes in Table 1 .
Enrichment analyses
Gene sets with an FDR , 0.3 are strongly enriched for genes under evolutionary constraint 19 (P 5 3.0 3 10 211 ; Fig. 1a and Supplementary  Table 4 ), consistent with the hypothesis that heterozygous LoF mutations in these genes are ASD risk factors. Over 5% of ASD subjects carry de novo LoF mutations in our FDR , 0.3 list. We also observed that genes in the FDR , 0.3 list had a significant excess of de novo nonsynonymous events detected by the largest schizophrenia WES study so far 30 (P 5 0.0085; Fig. 1a ), providing further evidence for overlapping risk loci between these disorders and independent confirmation of the signal in the gene sets presented here.
We found significant enrichment for genes encoding messenger RNAs targeted by two neuronal RNA-binding proteins: FMRP 31 (also known as FMR1), mutated or absent in fragile X syndrome (P 5 1.20 3 10 217 , 34 targets 31 , of which 11 are corroborated by an independent data set 32 ), and RBFOX (RBFOX1/2/3) (P 5 0.0024, 20 targets, of which 12 overlap with FMRP), with RBFOX1 shown to be a splicing factor dysregulated in ASD 33, 34 (Fig. 1a ). These two pathways expand the complexity of ASD neurobiology to post-transcriptional events, including splicing and translation, both of which sculpt the neural proteome.
We found nominal enrichment for human orthologues of mouse genes encoding synaptic (P 5 0.031) and post-synaptic density (PSD) proteins 35 (P 5 0.046; Fig. 1a, b and Supplementary Tables 4-6 ). Enrichment analyses for InterPro, SMART or Pfam domains (FDR , 0.05 and a minimum of five genes per category) reveal an overrepresentation of DNA-or histone-related domains: eight genes encoding proteins with InterPro zinc-finger FYVE PHD domains (142 such annotated genes in the genome; FDR 5 7.6 3 10 24 ), and five with Pfam Su(var)3-9, enhancer-of-zeste, trithorax (SET) domains (39 annotated in the genome; FDR 5 8.2 3 10 24 ).
Integrating complementary data
To implicate additional genes in risk for ASD, we used a model called DAWN (detecting association with networks) 36 . DAWN evokes a hidden Markov random field framework to identify clusters of genes that show strong association signals and highly correlated co-expression in a key tissue and developmental context. Previous research suggests human mid-fetal prefrontal and motor-somatosensory neocortex is a critical nexus for risk 16 , thus we evaluated gene co-expression data from that tissue together with TADA scores for genes with an FDR , 0.3. Because this list is enriched for genes under evolutionary constraint, we generalized DAWN to incorporate constraint scores (Supplementary Information). When TADA results, gene co-expression in mid-fetal neocortex and constraint scores are jointly modelled, DAWN identifies 160 genes that plausibly affect risk (Fig. 2) , 91 of which are not in the 107 TADA genes with an FDR , 0.3. Moreover, the model parameter describing evolutionary constraint is an important predictor of clusters of putative risk genes (P 5 0.018).
A subnetwork obtained by seeding the 160 DAWN genes within a high-confidence protein-protein interactome 14 confirmed that the putative genes are enriched for neuronal functions. We kept the largest connected component, containing 95 seed DAWN genes, 50 of which were in the FDR , 0.3 gene set. The DAWN gene products form four natural 
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clusters on the basis of network connectivity (Fig. 2) . We visualized the enriched pathways and biological functions for each of these clusters on 'canvases' 37 (Extended Data Fig. 6 ). Many of the previously known ASD risk genes fall in cluster C3, including genes involved in synaptic transmission and cell-cell communication. Cluster C4 is enriched for genes related to transcriptional and chromatin regulation. Many TADA and DAWN genes in this cluster interact tightly with other transcription factors, histone-modifying enzymes and DNA-binding proteins. Five TADA genes in the cluster C2 are bridged to the rest of the network through MAPT, as inferred by DAWN. The enrichment results for cluster C2 indicate that genes implicated in neurodegenerative disorders could also have a role in neurodevelopmental disorders.
Emergent results
Amongst the critical synaptic components found to be mutated in our study are voltage-gated ion channels involved in fundamental processes including the propagation of action potentials (for example, the Na v 1.2 channel), neuronal pacemaking and excitability-transcription coupling (for example, the Ca v 1.3 channel) ( Fig. 1b) . We identified four LoF and five Mis3 variants in SCN2A (Na v 1.2), three Mis3 variants in CACNA1D (Ca v 1.3) and two LoF variants in CACNA2D3 (a 2 d-3 subunit). Remarkably, three de novo Mis3 variants in SCN2A affected residues mutated in homologous genes in patients with other syndromes, including Brugada syndrome (SCN5A) or epilepsy disorders (SCN1A) (Arg379His and Arg 937His). These arginines, as well as the threonine mutated in Thr1420Met, cluster to the P-loops forming the ion selectivity filter, located in proximity to the inner ring (DEKA motif) ( Fig. 1c ). Because homologous channels mutated in these arginines do not conduct inward Na 1 currents 38, 39 , Arg379His and Arg937His mutations might have similar effect. Two de novo CACNA1D variants (Gly407Arg and Ala749Gly) emerged at positions proximal to residues mutated in patients with primary aldosteronism and neurological deficits (Fig. 1d ). The reported mutations interfere with channel activation and inactivation 40 . Amongst variants found in cases, Ala59Val maps to the NSCaTE domain, also important for Ca 21 -dependent inactivation, and Ser1977Leu and Arg2021His cocluster in the carboxy-terminal proline-rich domain, the site of interaction with SHANK3, a key PSD scaffolding protein. Mutations in RIMS1 and RIMBP2, which can associate with Ca v 1.3, were found in our cohort (but with an FDR . 0.3).
Chromatin remodelling involves histone-modifying enzymes (encoded by histone-modifier genes, HMGs) and chromatin remodellers (readers) that recognize specific histone post-translational modifications and orchestrate their effects on chromatin. Our gene set is enriched in HMGs (9 HMGs out of 152 annotated in HIstome 41 , Fisher's exact test, P 5 2.2 3 10 27 ). Enrichment in the gene ontology term 'histone-lysine Nmethytransferase activity' (5 genes out of 41 so annotated; FDR 5 2.2 3 10 22 ) highlights this as a prominent pathway.
Lysines on histones 3 and 4 can be mono-, di-or tri-methylated, providing a versatile mechanism for either activation or repression of transcription. Of 107 TADA genes, five are SET lysine methyltransferases, four are jumonji lysine demethylases, and two are readers (Fig. 3a) . RBFOX1 co-isolates with histone H3 trimethyl Lys 4 (H3K4me3) 42 , and our data set is enriched in targets shared by RBFOX1 and H3K4me3 (P 5 0.0166; Fig. 1a and Supplementary Table 4 ). Some de novo missense variants targeting these genes map to functional domains (Extended Data Fig. 7) .
For the H3K4me2 reader CHD8, we extended our analyses in search of additional de novo variation in the cases of the case-control sample. By sequencing complete parent-child trios for many CHD8 variants, five variants were found to be de novo, two of which affect essential splice sites and cause LoF by exon skipping or activation of cryptic splice sites in lymphoblastoid cells (Fig. 3b) .
Given the role of HMGs in transcription, we reasoned that TADA genes might be interconnected through transcription 'routes'. We searched for a connected network (seeded by 9 TADA HMGs) in a transcription factor interaction network (ChEA) 43 . We found that 46 TADA genes are directly interconnected in a 55-gene cluster (Extended Data Fig. 8 ) (P 5 0.002; 1,000 random draws), for a total of 69 when including all known HMGs (Fig. 4 ) (P 5 0.001; 1,000 random draws).
Examining the Human Gene Mutation Database we found that the 107 TADA genes included 21 candidate genes for intellectual disability, 3 for epilepsy, 17 for schizophrenia, 9 for congenital heart disease and 6 for metabolic disorders (Fig. 5 ).
Conclusions
Complementing earlier reports, ASD subjects show a clear excess of de novo LoF mutations above expectation, with a concentration of such events in a handful of genes. While this handful has a large effect on risk, most ASD genes have a much smaller impact. This gradient emerges most notably from the contrast of risk variation in male and female ASD subjects. Unlike some earlier studies, but consistent with expectation, the data also show clear evidence for effect of de novo missense SNVs 
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on risk; for risk generated by LoF variants transmitted from unaffected parents; and for the value of case-control design in gene discovery. By integrating data on de novo, inherited and case-control variation, the yield of ASD gene discoveries was doubled over what would be obtained from a count of de novo LoF variants alone. ASD genes almost uniformly show strong constraints against variation, a feature we exploit to implicate other genes in risk. Three critical pathways for typical development are damaged by risk variation: chromatin remodelling, transcription and splicing, and synaptic function. Chromatin remodelling controls events underlying the formation of neural connections, including neurogenesis and neural differentiation 44 , and relies on epigenetic marks as post-translational modifications of histones . Here we provide extensive evidence for HMGs and readers in sporadic ASD, implicating specifically lysine methylation and extending the mutational landscape of the emergent ASD gene CHD8 to missense variants. Splicing is implicated by the enrichment of RBFOX targets in the top ASD candidates. Risk variation also affects multiple classes and components of synaptic networks, from receptors and ion channels to scaffolding proteins. Because a wide set of synaptic genes is disrupted in idiopathic ASD, it seems reasonable to suggest that altered chromatin dynamics and transcription, induced by disruption of relevant genes, leads to impaired synaptic function as well. De novo mutations in ASD [11] [12] [13] [14] [15] , intellectual disability 45 and schizophrenia 30 cluster to synaptic genes, and synaptic defects have been reported in models of these disorders 46 . Integrity of synaptic function is essential for neural physiology, and its perturbation could represent the intersection between diverse neuropsychiatric disorders 47 .
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Supplementary Table 1 . DNA was obtained, and exomes were captured and sequenced. After variant calling, quality control was performed: duplicate subjects and incomplete families were removed and subjects with extreme genotyping, de novo, or variant rates were removed. Following cleaning, 3,871 subjects with ASD remained. Analysis proceeded separately for SNVs and indels, and CNVs. De novo and transmission/nontransmission variants were obtained for trio data (published de novo variants from 825 trios 11, [13] [14] [15] were incorporated). This led to the TADA analysis, which found 33 ASD risk genes with an FDR , 0.1; and 107 with an FDR , 0.3. CNVs were called in 2,305 ASD subjects. BAM, binary alignment/map; MAF, minor allele frequency. The multiple LoF test (red) is a restricted version of TADA that uses only the de novo LoF data. TADA (blue) models de novo LoF, de novo Mis3, LoF variants transmitted/not transmitted and LoF variants observed in case-control samples. The sample size (n) indicates either n trios for which we record de novo and transmitted variation (TADA), or n trios for which we record only de novo events (multiple LoF), plus n cases and n controls. 
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